Interstitial lung disease in connective tissue disorders
A Fischer, R Du Bois - The lancet, 2012 - thelancet.com
Some of the most pressing challenges associated with interstitial lung disease (ILD) are how
best to define, diagnose, and treat connective tissue disease-associated ILD (CTD-ILD) …
best to define, diagnose, and treat connective tissue disease-associated ILD (CTD-ILD) …
The pathogenesis of pulmonary fibrosis: a moving target
WA Wuyts, C Agostini, KM Antoniou… - European …, 2013 - Eur Respiratory Soc
Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is
characterised by excessive matrix formation leading to destruction of the normal lung …
characterised by excessive matrix formation leading to destruction of the normal lung …
COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis
Unbiased genetic studies have uncovered surprising molecular mechanisms in human
cellular immunity and autoimmunity. We performed whole-exome sequencing and targeted …
cellular immunity and autoimmunity. We performed whole-exome sequencing and targeted …
Interstitial lung disease in connective tissue disease—mechanisms and management
AU Wells, CP Denton - Nature Reviews Rheumatology, 2014 - nature.com
Pulmonary complications are an important extra-articular feature of autoimmune rheumatic
diseases and a major cause of mortality. The underlying pathogenesis probably involves …
diseases and a major cause of mortality. The underlying pathogenesis probably involves …
Autoimmune-featured interstitial lung disease: a distinct entity
R Vij, I Noth, ME Strek - Chest, 2011 - Elsevier
Background Patients with interstitial lung disease (ILD) may have features of an autoimmune
disorder that do not meet the diagnostic criteria for connective tissue diseases. We …
disorder that do not meet the diagnostic criteria for connective tissue diseases. We …
Connective tissue disease-associated interstitial lung disease: a call for clarification
A Fischer, SG West, JJ Swigris, KK Brown, RM Du Bois - Chest, 2010 - Elsevier
This commentary highlights the present dilemmas surrounding the classification of a patient
with interstitial pneumonia who has clinical features suggesting an associated connective …
with interstitial pneumonia who has clinical features suggesting an associated connective …
Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease
JJ Swigris, AL Olson, A Fischer, DA Lynch… - Chest, 2006 - Elsevier
Background Interstitial lung disease (ILD) frequently complicates connective tissue diseases
(CTDs). Glucocorticoids and immunomodulatory agents are regarded as mainstays of …
(CTDs). Glucocorticoids and immunomodulatory agents are regarded as mainstays of …
[Translated article] Biological Biomarkers in Respiratory Diseases
F García-Río, B Alcázar-Navarrete… - Archivos de …, 2022 - Elsevier
In recent years, personalized or precision medicine has made effective inroads into the
management of diseases, including respiratory diseases. The route to implementing this …
management of diseases, including respiratory diseases. The route to implementing this …
Pulmonary manifestations of systemic lupus erythematosus
DL Kamen, C Strange - Clinics in chest medicine, 2010 - chestmed.theclinics.com
Systemic lupus erythematosus (SLE) is a potentially severe, frequently disabling
autoimmune disease with multiorgan involvement and a typically waxing and waning …
autoimmune disease with multiorgan involvement and a typically waxing and waning …
Subclinical interstitial lung disease: why you should care
TJ Doyle, GM Hunninghake, IO Rosas - American journal of …, 2012 - atsjournals.org
The widespread use of high-resolution computed tomography in clinical and research
settings has increased the detection of interstitial lung abnormalities (ILA) in asymptomatic …
settings has increased the detection of interstitial lung abnormalities (ILA) in asymptomatic …